X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-04-18 | BEEP | Mobile Infrastructure Corp | Chavez Manuel III | CEO, 10% | P - Purchase | $3.41 | +33,043 | 5,786,734 | +1% | +$112,677 | ||||||
| M | 2024-04-17 | EXFY | Expensify, Inc. | McLaughlin Steven J. | 10% | P - Purchase | $1.51 | +143,639 | 10,781,735 | +1% | +$216,222 | |||||
| D | 2024-04-18 | CDZI | Cadiz Inc | Kennedy Susan P | CEO | P - Purchase | $2.25 | +25,000 | 966,921 | +3% | +$56,250 | |||||
| M | 2024-04-17 | CLSD | Clearside Biomedical, Inc. | Gibney Anthony S | Dir | P - Purchase | $1.30 | +100,000 | 100,000 | New | +$129,665 | |||||
2024-04-17 | BEEP | Mobile Infrastructure Corp | Chavez Manuel III | CEO, 10% | P - Purchase | $3.45 | +16,861 | 5,753,691 | 0% | +$58,170 | ||||||
2024-04-16 | EAF | Graftech International Ltd | Colonial House Capital Ltd | 10% | P - Purchase | $1.78 | +2,303,599 | 29,535,575 | +8% | +$4,100,867 | ||||||
2024-04-15 | PETV | Petvivo Holdings, Inc. | Lai John | CEO, Pres | P - Purchase | $0.60 | +150,000 | 1,288,592 | +13% | +$90,000 | ||||||
| M | 2024-04-15 | BRN | Barnwell Industries Inc | Sherwood Ned L | 10% | P - Purchase | $2.69 | +88,411 | 2,855,865 | +3% | +$237,699 | |||||
| M | 2024-04-15 | EXFY | Expensify, Inc. | McLaughlin Steven J. | 10% | P - Purchase | $1.44 | +324,791 | 10,638,096 | +3% | +$466,734 | |||||
| M | 2024-04-15 | BCOV | Brightcove Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $1.69 | +56,831 | 6,512,633 | +1% | +$95,857 | |||||
2024-04-11 | JETMF | Global Crossing Airlines Group Inc. | Red Oak Partners, LLC | 10% | P - Purchase | $0.38 | +722,581 | 4,505,537 | +19% | +$274,581 | ||||||
| D | 2024-04-15 | AINC | Ashford Inc. | Bennett Monty J | CEO, COB, 10% | P - Purchase | $4.91 | +200,000 | 685,511 | +41% | +$982,000 | |||||
| DM | 2024-03-20 | PKTX | Protokinetix, Inc. | Smith Clarence Edward | Pres, CEO, 10% | P - Purchase | $0.01 | +3,166,667 | 77,137,093 | +4% | +$35,000 | |||||
| D | 2024-04-11 | OCX | Oncocyte Corp | Broadwood Partners, L.P. | 10% | P - Purchase | $2.92 | +2,420,000 | 9,858,289 | +33% | +$7,057,688 | |||||
2024-04-11 | OCX | Oncocyte Corp | Arno Andrew | Dir | P - Purchase | $2.95 | +33,898 | 84,662 | +67% | +$99,999 | ||||||
| D | 2024-04-09 | RYES | Rise Gold Corp. | Oliver Daniel Jr | Dir, 10% | P - Purchase | $0.10 | +2,700,000 | 10,011,737 | +37% | +$256,500 | |||||
| DM | 2024-04-10 | LGVN | Longeveron Inc. | Hare Joshua | Chief Scientific Officer, 10% | P - Purchase | $2.35 | +148,936 | 633,280 | +31% | +$350,000 | |||||
| DM | 2024-04-10 | LGVN | Longeveron Inc. | Soffer Rock | Dir | P - Purchase | $2.35 | +138,298 | 208,534 | +197% | +$325,000 | |||||
| M | 2024-04-10 | BCOV | Brightcove Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $1.75 | +15,175 | 6,455,802 | 0% | +$26,586 | |||||
2024-04-10 | ATOS | Atossa Therapeutics, Inc. | Finn Jonathan | Dir | P - Purchase | $1.77 | +25,000 | 25,000 | New | +$44,250 | ||||||
2024-04-04 | NXMH | Next Meats Holdings, Inc. | White Knight Co., Ltd. | 10% | P - Purchase | $0.01 | +9,584,227 | 212,508,202 | +5% | +$138,971 | ||||||
2024-04-04 | NXMH | Next Meats Holdings, Inc. | Ishizuka Koichi | CEO, CFO, 10% | P - Purchase | $0.01 | +9,584,227 | 312,959,322 | +3% | +$138,971 | ||||||
| DM | 2024-04-08 | LCGMF | Lion Copper & Gold Corp. | Alford Tony L | Dir, 10% | P - Purchase | $0.06 | +5,072,683 | 113,590,986 | +5% | +$309,296 | |||||
2024-04-08 | DOMH | Dominari Holdings Inc. | Wool Kyle Michael | Pres, 10% | P - Purchase | $2.99 | +8,500 | 1,517,397 | +1% | +$25,390 | ||||||
2024-04-09 | ANIX | Anixa Biosciences Inc | Titterton Lewis H Jr | Dir | P - Purchase | $3.28 | +15,009 | 838,037 | +2% | +$49,230 | ||||||
2024-04-08 | FLGC | Flora Growth Corp. | Starke Clifford | CEO | P - Purchase | $1.90 | +526,315 | 1,340,056 | +65% | +$999,999 | ||||||
| M | 2024-04-04 | ALDX | Aldeyra Therapeutics, Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $4.68 | +177,993 | 9,275,851 | +2% | +$833,867 | |||||
2024-04-04 | DOMH | Dominari Holdings Inc. | Wool Kyle Michael | Pres, 10% | P - Purchase | $2.87 | +19,000 | 28,000 | +211% | +$54,511 | ||||||
| M | 2024-04-04 | DOMH | Dominari Holdings Inc. | Hayes Anthony | CEO | P - Purchase | $2.82 | +17,444 | 334,754 | +5% | +$49,162 | |||||
| M | 2024-04-02 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $1.10 | +42,044 | 15,265,481 | 0% | +$46,383 | |||||
| A | 2024-03-28 | AMPS | Altus Power, Inc. | Felton Gregg J | CO-FOUNDER CO-CEO CO-Pres, 10% | P - Purchase | $4.78 | +12,500 | 15,989,460 | 0% | +$59,750 | |||||
2024-04-04 | BUKS | Butler National Corp | Daly Joseph Patrick | Dir, 10% | P - Purchase | $0.79 | +89,200 | 8,000,000 | +1% | +$70,216 | ||||||
| D | 2024-04-02 | MTEM | Molecular Templates, Inc. | Biotech Target N V | 10% | P - Purchase | $2.35 | +250,000 | 1,279,820 | +24% | +$587,500 | |||||
2024-03-19 | HFUS | Hartford Great Health Corp. | Wang Rose Hong | Former CEO & Director* | P - Purchase | $0.02 | +2,940,000 | 3,664,000 | +406% | +$58,800 | ||||||
2024-03-13 | HFUS | Hartford Great Health Corp. | Lu Yuan | Dir | P - Purchase | $0.02 | +4,900,000 | 4,910,000 | >999% | +$98,000 | ||||||
2024-03-13 | HFUS | Hartford Great Health Corp. | Dong Xin | Dir | P - Purchase | $0.02 | +4,900,000 | 4,910,000 | >999% | +$98,000 | ||||||
2024-03-19 | HFUS | Hartford Great Health Corp. | Song Lianyue | 10% | P - Purchase | $0.02 | +9,674,000 | 68,184,880 | +17% | +$193,480 | ||||||
| D | 2024-04-02 | XLO | Xilio Therapeutics, Inc. | Gilead Sciences, Inc. | 10% | P - Purchase | $0.76 | +485,250 | 7,345,473 | +7% | +$368,790 | |||||
| M | 2024-04-01 | ALDX | Aldeyra Therapeutics, Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $3.84 | +504,272 | 9,097,858 | +6% | +$1,934,505 | |||||
| M | 2024-04-02 | CVV | Cvd Equipment Corp | Africk Andrew | 10% | P - Purchase | $4.98 | +217,554 | 1,248,082 | +21% | +$1,084,162 | |||||
| M | 2024-03-14 | NRDE | Nu Ride Inc. | Sole Andrew L. | Dir | P - Purchase | $2.30 | +542,566 | 700,000 | +345% | +$1,245,308 | |||||
| M | 2024-03-27 | FRTX | Fresh Tracks Therapeutics, Inc. | Exploration Capital, LLC | 10% | P - Purchase | $0.90 | +54,574 | 2,037,426 | +3% | +$49,113 | |||||
2024-03-28 | GANX | Gain Therapeutics, Inc. | Riley Jeffrey Scott | Dir | P - Purchase | $3.86 | +30,000 | 30,000 | New | +$115,770 | ||||||
| D | 2024-03-28 | GUER | Guerrilla Rf, Inc. | Pratt Ryan Michael | CEO, 10% | P - Purchase | $2.50 | +33,822 | 1,137,386 | +3% | +$84,555 | |||||
2024-03-28 | AMPS | Altus Power, Inc. | Felton Gregg J | CO-FOUNDER CO-CEO CO-Pres, 10% | P - Purchase | $4.78 | +12,500 | 15,584,463 | 0% | +$59,750 | ||||||
| A | 2024-02-28 | AGFY | Agrify Corp | Chang Raymond Nobu | CEO, COB, 10% | P - Purchase | $0.38 | +1,842,104 | 3,297,221 | +127% | +$700,000 | |||||
2024-03-28 | EYEN | Eyenovia, Inc. | Grant Stuart M. | 10% | P - Purchase | $0.98 | +100,000 | 5,430,715 | +2% | +$98,000 | ||||||
2024-03-28 | BMXI | Brookmount Explorations Inc | Pittman Jeffrey Stephen | Dir | P - Purchase | $0.03 | +800,000 | 963,118 | +490% | +$25,360 | ||||||
2024-03-18 | CBSTF | Cannabist Co Holdings Inc. | Clarke Jeff | Dir | P - Purchase | $0.26 | +100,000 | 802,947 | +14% | +$26,360 | ||||||
| M | 2024-03-27 | SMMT | Summit Therapeutics Inc. | Zanganeh Mahkam | CEO | P - Purchase | $3.73 | +110,321 | 25,494,614 | 0% | +$411,094 | |||||
2024-03-26 | SMMT | Summit Therapeutics Inc. | Dhingra Ankur | CFO | P - Purchase | $3.75 | +100,000 | 354,958 | +39% | +$375,000 | ||||||
2024-03-26 | FTCI | Ftc Solar, Inc. | Chatila Ahmad R | Dir | P - Purchase | $0.51 | +97,400 | 967,458 | +11% | +$49,674 | ||||||
2024-03-25 | DERM | Journey Medical Corp | Rosenwald Lindsay A Md | Dir | P - Purchase | $3.04 | +10,000 | 320,715 | +3% | +$30,400 | ||||||
| M | 2023-09-08 | NORD | Nordicus Partners Corp | Gk Partners Aps | 10% | P - Purchase | $1.00 | +984,500 | 2,216,044 | +80% | +$984,500 | |||||
2024-03-25 | UBI | Universal Biosensors Inc | Coleman Craig E. | Dir, 10% | P - Purchase | $0.20 | +1,000,000 | 61,392,221 | +2% | +$200,000 | ||||||
2024-03-25 | PHX | Phx Minerals Inc. | Behrman Mark T | Dir | P - Purchase | $3.22 | +23,000 | 173,704 | +15% | +$74,047 | ||||||
| M | 2024-03-22 | DSGN | Design Therapeutics, Inc. | Schmid John P. | Dir | P - Purchase | $3.70 | +26,965 | 57,639 | +88% | +$99,738 | |||||
2024-03-22 | DERM | Journey Medical Corp | Maraoui Claude | Pres, CEO | P - Purchase | $3.48 | +10,000 | 2,163,430 | 0% | +$34,790 | ||||||
2024-03-22 | DERM | Journey Medical Corp | Smith Justin Adam | Dir | P - Purchase | $3.47 | +30,000 | 134,717 | +29% | +$104,100 | ||||||
2024-03-22 | DERM | Journey Medical Corp | Rosenwald Lindsay A Md | Dir | P - Purchase | $3.40 | +20,000 | 310,715 | +7% | +$68,000 | ||||||
2024-03-20 | CYT | Cyteir Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $2.95 | +170,589 | 3,989,053 | +4% | +$503,238 | ||||||
2024-03-22 | IMRX | Immuneering Corp | Feinberg Peter | Dir | P - Purchase | $2.55 | +25,000 | 1,096,064 | +2% | +$63,713 | ||||||
2024-03-22 | FTCI | Ftc Solar, Inc. | Chatila Ahmad R | Dir | P - Purchase | $0.55 | +92,600 | 870,058 | +12% | +$50,930 | ||||||
| DM | 2024-01-03 | HMLA | Himalaya Technologies, Inc | Grover Vikram P | CEO, CFO, Secretary, 10% | P - Purchase | $0.00 | +24,390,004 | 24,390,004 | New | +$25,680 | |||||
2024-03-20 | BCOV | Brightcove Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $1.88 | +30,000 | 6,435,437 | 0% | +$56,250 | ||||||
2024-03-21 | CIA | Citizens, Inc. | Shields Gerald | Pres, CEO | P - Purchase | $2.22 | +16,000 | 168,724 | +10% | +$35,520 | ||||||
2024-03-21 | NYCB | New York Community Bancorp, Inc. | Lux Marshall | Dir | P - Purchase | $3.69 | +27,100 | 76,092 | +55% | +$99,891 | ||||||
2024-03-20 | BW | Babcock & Wilcox Enterprises, Inc. | Young Kenneth M | CEO | P - Purchase | $1.03 | +29,229 | 1,521,412 | +2% | +$30,001 | ||||||
2024-03-19 | CIO | City Office Reit, Inc. | Mazan Michael | Dir | P - Purchase | $4.22 | +39,000 | 39,000 | New | +$164,771 | ||||||
2024-03-20 | FTCI | Ftc Solar, Inc. | Chatila Ahmad R | Dir | P - Purchase | $0.54 | +92,500 | 777,458 | +14% | +$49,950 | ||||||
2024-03-19 | DCTH | Delcath Systems, Inc. | Aharon Gil | Dir | P - Purchase | $3.72 | +26,882 | 1,069,710 | +3% | +$100,001 | ||||||
2024-03-19 | DCTH | Delcath Systems, Inc. | Salamon Steven A J | Dir | P - Purchase | $3.72 | +26,882 | 1,121,025 | +2% | +$100,001 | ||||||
2024-03-18 | NN | Nextnav Inc. | Samberg Joseph D | 10% | P - Purchase | $4.52 | +483,000 | 12,265,000 | +4% | +$2,181,663 | ||||||
2024-03-18 | STEM | Stem, Inc. | Buzby David S | Dir | P - Purchase | $1.81 | +33,800 | 1,327,159 | +3% | +$61,178 | ||||||
2024-03-19 | EYEN | Eyenovia, Inc. | Grant Stuart M. | 10% | P - Purchase | $1.23 | +50,000 | 5,330,715 | +1% | +$61,500 | ||||||
| M | 2024-03-18 | NN | Nextnav Inc. | Subin Neil S | Dir | P - Purchase | $4.59 | +150,000 | 4,191,347 | +4% | +$688,000 | |||||
2024-03-18 | OVID | Ovid Therapeutics Inc. | Levin Jeremy M | CEO | P - Purchase | $2.76 | +18,248 | 3,652,176 | +1% | +$50,364 | ||||||
2024-03-19 | TRCK | Track Group, Inc. | Sehnaoui Karim | Dir | P - Purchase | $0.27 | +370,000 | 388,421 | >999% | +$99,900 | ||||||
2024-03-20 | CLSD | Clearside Biomedical, Inc. | Chong Ngai Hang Victor | CHIEF MEDICAL OFFICER | P - Purchase | $1.60 | +30,000 | 30,000 | New | +$48,000 | ||||||
2024-03-18 | OCUP | Ocuphire Pharma, Inc. | Magrath George | CEO | P - Purchase | $1.96 | +25,000 | 425,000 | +6% | +$49,050 | ||||||
| M | 2024-03-19 | MKTW | Marketwise, Inc. | Tongue Glenn H | Dir | P - Purchase | $1.72 | +15,000 | 161,814 | +10% | +$25,750 | |||||
2024-03-19 | MHLD | Maiden Holdings, Ltd. | Lyons Simcha G | Dir | P - Purchase | $1.80 | +15,000 | 206,525 | +8% | +$27,027 | ||||||
| DM | 2024-01-03 | HMLA | Himalaya Technologies, Inc | Grover Vikram P | CEO, CFO, Secretary, 10% | P - Purchase | $0.00 | +24,390,004 | 24,390,004 | New | +$25,680 | |||||
| D | 2024-03-15 | XELB | Xcel Brands, Inc. | Disanto Mark | Dir | P - Purchase | $0.65 | +146,250 | 1,425,744 | +11% | +$95,063 | |||||
2024-03-15 | XELB | Xcel Brands, Inc. | D Loren Robert W | CEO, COB, 10% | P - Purchase | $0.65 | +146,250 | 2,625,146 | +6% | +$95,063 | ||||||
| M | 2024-03-15 | STKS | One Group Hospitality, Inc. | Kanen David | See Explanation of Responses, 10% | P - Purchase | $3.89 | +272,421 | 4,863,312 | +6% | +$1,059,498 | |||||
2024-03-18 | IMRX | Immuneering Corp | Berman Ann E | Dir | P - Purchase | $2.13 | +57,965 | 67,465 | +610% | +$123,436 | ||||||
| M | 2024-03-18 | IMRX | Immuneering Corp | Feinberg Peter | Dir | P - Purchase | $2.44 | +75,000 | 1,071,064 | +8% | +$183,058 | |||||
| E | 2024-03-15 | REEMF | Rare Element Resources Ltd | Synchron | 10% | P - Purchase | $0.12 | +244,383,591 | 360,740,516 | +210% | +$29,326,030 | |||||
2024-03-19 | IMRX | Immuneering Corp | Zeskind Benjamin J. | Pres, CEO, 10% | P - Purchase | $2.77 | +20,000 | 3,176,779 | +1% | +$55,326 | ||||||
| A | 2023-12-15 | SST | System1, Inc. | Blend Stanley | 10% | P - Purchase | $1.42 | +880,281 | 6,613,237 | +15% | +$1,249,999 | |||||
| DM | 2024-03-18 | LIPO | Lipella Pharmaceuticals Inc. | Kaufman Jonathan H | See remarks below., 10% | P - Purchase | $0.83 | +55,000 | 888,849 | +7% | +$45,452 | |||||
2024-03-15 | SWIM | Latham Group, Inc. | Gloe Oliver C. | CFO | P - Purchase | $2.92 | +27,500 | 292,922 | +10% | +$80,300 | ||||||
2024-03-18 | CYT | Cyteir Therapeutics, Inc. | Leonard Braden Michael | 10% | P - Purchase | $3.01 | +113,777 | 3,818,464 | +3% | +$342,469 | ||||||
2024-03-15 | CORZ | Core Scientific, Inc./Tx | Patten Jarrod M | Dir | P - Purchase | $3.32 | +100,000 | 100,000 | New | +$332,220 | ||||||
2024-03-15 | CORZ | Core Scientific, Inc./Tx | Becker Todd A | Dir | P - Purchase | $3.16 | +130,000 | 134,250 | >999% | +$410,163 | ||||||
| M | 2021-10-15 | RZLT | Rezolute, Inc. | Handok, Inc. | Dir, 10% | P - Purchase | $4.33 | +3,927,126 | 5,942,617 | +195% | +$17,000,003 | |||||
2024-03-18 | MGLD | Marygold Companies, Inc. | Nicholas & Melinda Gerber Living Trust | CEO, 10% | P - Purchase | $1.36 | +50,000 | 18,338,766 | 0% | +$68,000 | ||||||
2022-04-13 | NKPH | Nika Pharmaceuticals, Inc | Nika Pharmaceuticals, Inc | Pres, CEO, CFO, 10% | P - Purchase | $0.01 | +11,489,000 | 10,000,000 | -772% | +$137,868 | ||||||
2024-03-18 | CBSTF | Cannabist Co Holdings Inc. | Hart David James | CEO | P - Purchase | $0.26 | +100,000 | 1,210,153 | +9% | +$26,350 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |